Edgewise Therapeutics, Inc.EWTXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-158.83M
↓ 130% below average
Average (5y)
$-69.20M
Historical baseline
Range
High:$-9.92M
Low:$-158.83M
CAGR
+74.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-158.83M | -38.9% |
| 2023 | $-114.36M | -59.6% |
| 2022 | $-71.66M | -65.8% |
| 2021 | $-43.22M | -151.4% |
| 2020 | $-17.19M | -73.2% |
| 2019 | $-9.92M | - |